TrademarkDir
DIVERSIMAB
LIVE

Serial Number

90825952

Owner

AbX Biologics, Inc.

Attorney

Mark Leonardo

First Use Date

Nov 1, 2014

Filing Date

Jul 13, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DIVERSIMAB Trademark

Serial Number: 90825952 • Registration: 6862661

DIVERSIMAB is a trademark filed by AbX Biologics, Inc. on July 13, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AbX Biologics, Inc. (2 trademarks)

480 Neponset Street, Suite 10B
Canton, MA 02021

Entity Type: 03

Trademark Details

Filing Date

July 13, 2021

Registration Date

October 4, 2022

First Use Anywhere

November 1, 2014

First Use in Commerce

November 1, 2014

Published for Opposition

July 19, 2022

Goods & Services

Scientific research services for others in the field of genetics and monoclonal antibodies; Research and development services in the field of monoclonal antibodies, namely, development of antibody-based therapeutics and discovery of reagents; Research and development services in the field of monoclonal antibodies, namely, generation of therapeutic and reagent antibodies; Genetic engineering services, namely, the production of genetically-engineered mice and monoclonal antibodies for others

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 4, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 4, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 14, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2021 NWOS
NEW APPLICATION ENTERED
Jul 16, 2021 NWAP

Related Trademarks

More from this Owner

DIVERGIMAB

DIVERGIMAB

DIVERGIMAB

DIVERGIMAB

DIVERGIMAB

DIVERGIMAB